(PharmaNewsWire.Com, April 14, 2022 ) The Injectable Drug Delivery Market is likely to grow stupendously in the subsequent decade. With IoT in the picture, the complex medical equipment could be monitored, that too, all at a time and under one umbrella. As such, costly downtime could be avoided and predictive maintenance could be fostered. Plus, increased spending could be facilitated for disposable items like syringes, gloves, and masks.
Over the years, there has been a rise in the demand for convenient and efficient drug delivery systems for patients that rely on prescription drugs on a regular basis. This creates a lucrative opportunity for pharmaceutical manufacturers all over the world to develop sophisticated, easy-to-use, and effective injectable drug delivery devices. Moreover, rise in the prevalence of chronic diseases such as diabetes, cancer, and rheumatoid arthritis are likely to fuel the growth of the injectable drug delivery market during the forecast period.
The global injectable drug delivery market was valued at US$ 30.5 Bn in 2018, and is expected to exhibit a CAGR of around 9% during the forecast period (2019–2029).
Company Profiles
Eli Lilly and Company Biocon Becton, Dickinson & Company West Pharmaceutical Services, Inc. Johnson & Johnson Antares Pharma AbbVie Inc. Pfizer Inc. Mylan N.V. Vetter Pharma-Fertigung GmbH & Co.KG Emperra GmbH
Key Takeaways of Injectable Drug Delivery Market Study
Insulin pens contributed the most share to the injectable drug delivery market in 2018, due to the rising prevalence of diabetes in developing countries. Non-smart injector technology accounted for a prominent share in the global injectable drug delivery market in 2018, due to increase in the adoption of advanced technology and rising demand for smartphone-integrated products. Rise in the demand for connected devices and the high cost of such devices offer growth opportunities for manufacturers of reusable injectable drug delivery devices. Diabetes indication is expected to continue to hold a prominent position in the injectable drug delivery market throughout the forecast period. Increase in the number of pharmaceutical manufacturers has contributed to the dominance of North America in the global injectable drug delivery market. Attributed to growing awareness regarding various diseases such as cancer and diabetes, East Asia is expected to register notable growth opportunities for the injectable drug delivery market.
“Smart injectable drug delivery devices not only improve patient compliance to treatment but also collect extensive data that is valuable for future research. Rising demand for connected injectable drug delivery devices will offer significant growth opportunity for the injectable drug delivery market,” says a PMR analyst.
How About Obtaining Insights About The Region To Enter Concerning The Injectable Drug Delivery Market? Press The “Purchase Now” Button To Have Our Injectable Drug Delivery Market Report! https://www.persistencemarketresearch.com/checkout/3774
Trends in Smart Injectable Drug Delivery Technologies
There are many research and pipeline products that will have the ability to connect with smartphones and trackers. However, current smart products are predominantly available as reusable devices. This is attributed to the current state of technology that requires further advancements to apply to disposable products. According to a number of studies and key opinion leaders in the industry, there are a number of factors that limit disposable injectable drug delivery devices from being integrated with smart/connecting technologies. Some of these factors include high cost of Bluetooth integration, low range connectivity with NFC, and lack of power source for connectivity. Thus, although disposable injectable drug delivery will continue holding a larger share throughout the forecast period, reusable injectable drug delivery devices have the potential to grow at a relatively faster rate, at least in the first five years of the forecast period.
More Valuable Insights on Injectable Drug Delivery Market
This report offers a unique perspective and actionable insights on the injectable drug delivery market in its latest study. The report presents historical demand assessment of 2014–2018 and projections for 2019–2029, on the basis of product (self-injectors, needle-free injectors, auto injectors, wearable injectors, and insulin pens), technology (non-smart injectors and smart injectors), usage (disposable injectors and reusable injectors), indication (anaphylaxis, diabetes, cardiovascular diseases, multiple sclerosis, rheumatoid arthritis, cancer, trauma and emergency, and others), and distribution channel (hospital pharmacies, drug stores, retail pharmacies, and online pharmacies), across seven regions.
Related Reports:
Pharmaceutical Excipients For Taste Masking Market - Increasing geriatric population and rising incidence of chronic diseases such as diabetes, cancer, and cardiovascular diseases will drive the growth of the Pharmaceutical Excipients For Taste Masking Market, globally, at a CAGR of over 5% through 2030.
Cancer Supportive Care Products Market - Global Cancer Supportive Care Products Market across the world will translate into a revenue of US$ 31,700.0 Mn along with a healthy CAGR by the end of 2021.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
